Oppenheimer Asset Management’s Amedisys AMED Stock Holding History
Bought
Maintained
Sold
Other funds holding AMED
PCM
AAM
WCMNY
PWAM
Oppenheimer Asset Management's AMED Position: Q3 2023 in Review
Oppenheimer Asset Management sold out of Amedisys (AMED) in Q3 2023, closing a stake of 69,083 shares — an estimated $6.32M sold.
Oppenheimer Asset Management first reported a position in AMED in Q2 2019 and held it in 17 quarters. The position peaked at $13.5M in Q1 2022. 286 funds tracked by Wall St. Rank hold AMED as of Q3 2023.
- Oppenheimer Asset Management reported no remaining Amedisys position as of Q3 2023 after selling out during the quarter.
- Oppenheimer Asset Management sold 69,083 Amedisys shares in Q3 2023, an estimated $6.32M.
- Oppenheimer Asset Management first reported a position in Amedisys in Q2 2019 and held it in 17 quarters.
- Oppenheimer Asset Management's Amedisys position peaked at $13.5M in Q1 2022.
- 286 funds tracked by Wall St. Rank held Amedisys as of Q3 2023.
Based on Oppenheimer Asset Management's 13F filing for Q3 2023, filed 8 Nov 2023.